Bansisons Tea Industries Limited , a tea company based in West Bengal, has announced a change in its board composition. Mrs. Mamy Ghosh (DIN: 06532484) has stepped down from her role as an Independent Director, effective November 19, 2025.

Resignation Details

Mrs. Ghosh cited pre-occupation as the primary reason for her departure from the board. In her resignation letter, she confirmed that there were no other material reasons for her decision beyond those stated.

Impact on Board Composition

The resignation of Mrs. Ghosh will affect the company's board structure. As an Independent Director, her role was crucial in providing unbiased oversight and guidance to the company's operations.

Company's Response

Bansisons Tea Industries Limited has acknowledged Mrs. Ghosh's resignation and has initiated the necessary procedural formalities under the Companies Act, 2013 and SEBI Regulations to give effect to the resignation.

Financial Context

While the resignation itself does not directly impact the company's financials, it's worth noting some key financial metrics of Bansisons Tea Industries Limited as of the most recent balance sheet data (March 2025):

These figures provide context to the company's financial position at the time of this board change.

Next Steps

The company may begin the process of identifying and appointing a new Independent Director to maintain the required board composition as per regulatory guidelines. Shareholders and investors will be keen to see how this change might influence the company's governance structure moving forward.

As this is a developing situation, stakeholders are advised to monitor further announcements from Bansisons Tea Industries Limited regarding potential replacements or changes to the board structure.

Bansisons Tea Industries Limited has announced significant corporate changes and is seeking shareholder approval through a postal ballot. The company plans to transform its business focus from tea operations to pharmaceutical manufacturing, research, and chemical activities.

Key Corporate Changes

These decisions signal a potential shift in the company's core business from tea to pharmaceuticals, as reflected in the proposed name change.

Postal Ballot and E-Voting

The company has issued a postal ballot notice to seek shareholder consent for the aforementioned changes. E-voting is scheduled to take place from November 29 to December 29, allowing shareholders to participate in this decision-making process.

Implications

These corporate actions, particularly the name change and object clause modification, suggest a strategic pivot for Bansisons Tea Industries. The move towards a pharmaceutical-oriented name and business object indicates a transformation in the company's future direction.

The proposed disposal of the West Bengal undertaking assets and liabilities could potentially provide the company with additional capital to fund this transition or strengthen its financial position for the new business venture.

Investors and stakeholders may want to closely monitor further announcements and the outcome of the postal ballot, as these changes could substantially impact the company's business model and future prospects.

As these changes require shareholder approval, the coming weeks will be crucial in determining the potential new direction of Bansisons Tea Industries Limited, soon to be known as Novyra Pharmachem Limited, pending shareholder approval.